Table 2.
Procedure characteristics of groupPRO, groupREDPRO and groupNOPRO
| Parameter | GroupPRO | GroupREDPRO | GroupNOPRO |
|---|---|---|---|
| Melphalan dose (mg; median (IQR) | 179 (152-203) | 200 (188-212) | 184 (166-201) |
| Fluoroscopy time (mm; median (IQR)) | 7 (2-14) | 12 (7-14) | 6 (5-19) |
| Intervention time (hh:mm; median (IQR)) | 02:45 (02:28-03:07) | - | 02:00 (01:54-02:15) |
| GroupPRO vs NOPRO:p=0.00001 | |||
| UFH Dose (I.U.; mean (IQR)) | 41 059 (32 125- 48 815) | 43 775 (37 375- 46 000) | 49 583 (40 000-60 000) |
| groupPRO vs REDPRO:p=0.368; groupPRO vs NOPRO:p=0.0006; groupREDPRO vs NOPRO:p=0.156 | |||
| Protamine sulfate (I.U.; mean (IQR)) | 34 141 (26 500- 40 000) | 27 368 (20 000- 35 000) | - |
| groupPRO vs REDPRO:p=0.036 | |||
Data of 97% of the interventions were available or this analysis
IQR Interquartile range, UFH Unfractionated heparin, I.U International unit